Form 4 for KTTA Pasithea Therapeutics Corp.
Accepted 2025-12-01 00:00:00 ET · period of report 2025-11-28 · accession 0001213900-25-116301 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-01 | 2025-11-28 | KTTA | Marques Tiago | CEO, Dir | P - Purchase | $0.75 | +33.3K | 73.3K | +83% | +$25.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-28 | P | A | 33,333 | $0.75 | 73,334 | D | — | — |